Mostrando 3 resultados de: 3
Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopus